38489-85-9

Usage

Uses

Used in Pharmaceutical Industry:
(4E)-4-[1-(hydroxyamino)ethylidene]-2-methoxycyclohexa-2,5-dien-1-one is used as a pharmaceutical compound for its potential therapeutic properties. Its unique structure and functional groups may contribute to the development of new drugs and treatments.
Used in Organic Synthesis:
(4E)-4-[1-(hydroxyamino)ethylidene]-2-methoxycyclohexa-2,5-dien-1-one is used as an intermediate in organic synthesis for the production of various chemical compounds. Its functional groups can be utilized in the synthesis of other complex molecules.
Used in Material Science:
(4E)-4-[1-(hydroxyamino)ethylidene]-2-methoxycyclohexa-2,5-dien-1-one is used in material science for the development of new materials with unique properties. Its structure and functional groups may contribute to the creation of innovative materials with potential applications in various industries.
However, it is important to note that further research and analysis are needed to fully understand the properties and potential uses of (4E)-4-[1-(hydroxyamino)ethylidene]-2-methoxycyclohexa-2,5-dien-1-one.

Upstream product

• 498-02-2 1-(3-methoxy-4-hydroxyphenyl)ethanone 

Downstream Products

• 24521-34-4 1-(3-methoxy-4-hydroxyphenyl)ethylamine hydrochloride 
• 134855-95-1 4-(1-aminoethyl)-2-methoxyphenol 
• 1391847-99-6 C₁₆H₂₆N₂O₄ 
• 1391847-98-5 C₂₁H₂₈N₂O₂S 
• 1391847-97-4 C₁₉H₃₁NO₃ 
• 1391847-96-3 C₁₈H₂₉NO₃ 
• 1391847-95-2 C₂₇H₄₅NO₃ 

Relevant academic research and scientific papers

APPLICATIONS OF N6-SUBSTITUTED ADENOSINE DERIVATIVE AND N6-SUBSTITUTED ADENINE DERIVATIVE TO CALMING, HYPNOSES, CONVULSION RESISTANCE, EPILEPTIC RESISTANCE, PARKINSON DISEASE RESISTANCE, AND DEMENTIA PREVENTION AND TREATMENT

PROBLEM TO BE SOLVED: To prepare analgesics, hypnotic agents, anticonvulsant agents, antiepileptics, antiparkinson drugs, dementia prophylactics, and health care food. SOLUTION: The present invention relates to an N6-substituted adenosine derivative and an N6-substituted adenine derivative selected from the group consisting of specific compounds. The present invention also relates to a pharmaceutical composition at least comprising a therapeutically effective amount of the compounds and a pharmaceutically acceptable carrier. The invention further relates to the compounds used in preparation of analgesics, hypnotic agents, anticonvulsant agents, antiepileptics, antiparkinson drugs, dementia prophylactics, and health care food. COPYRIGHT: (C)2016,JPO&INPIT

N6-SUBSTITUTED ADENOSINE DERIVATIVES AND N6-SUBSTITUTED ADENINE DERIVATIVES AND USES THEREOF

The present invention provides N6-substituted adenosine derivatives and N6-substituted adenine derivatives, manufacturing methods thereof, a pharmaceutical composition comprising the said compounds above, and uses of these compounds in manufacturing medicaments and health-care products for treating insomnia, convulsion, epilepsy, and Parkinson's diseases, and preventing and treating dementia.

The SAR analysis of TRPV1 agonists with the α-methylated B-region

A series of TRPV1 agonists with amide, reverse amide, and thiourea groups in the B-region and their corresponding α-methylated analogues were investigated. Whereas the α-methylation of the amide B-region enhanced the binding affinities and potencies as agonists, that of the reverse amide and thiourea led to a reduction in receptor affinity. The analysis indicated that proper hydrogen bonding as well as steric effects in the B-region are critical for receptor binding.

N6-SUBSTITUTED ADENOSINE DERIVATIVES, N6-SUBSTITUTED ADENINE DERIVATIVES AND USES THEREOF

The present invention provides N6-substituted adenosine derivatives and N6-substituted adenine derivatives, manufacturing methods thereof, a pharmaceutical composition comprising the said compounds above, and uses of of these compounds in manufacturing medicaments and health-care products for treating insomnia, convulsion, epilepsy, and Parkinson's diseases, and preventing and treating dementia.